Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizStatistical drivel in patent law analyses?
By Lawrence B. Ebert, Esq.
A recent patent reexamination analysis by lawyers is exemplary: a small sample size of biased data, rendering it rather meaningless. But the statistically-challenged authors reported the results as conclusive. Another study, on civil lawsuit settlements, suffers the same flaw. There at least the authors admit the data base as flawed, but regardless paint a brave face on tainted data. [concerning the analysis by Andrew S. Baluch and Stephen B. Maebius of Foley & Lardner.]
LBE posted a comment:
This evokes the completely bogus analysis by Professor John R. Thomas on the (allegedly high) grant rate of the first 100 published patent applications. Thomas neglected to point out that most of the first published applications had antecedent patent family members (ie, the first 100 were primarily not first filed cases). Biasing one's sample can lead to unusual results.
See IPBiz posts
Do the published applications of 2001 tell us about patent grant rate? (July 31, 2007)
More on patent grant rate; the USPTO is NOT a rubber stamp (August 2, 2007)
***Of course, then there is the godfather of bad analysis in the patent grant rate saga, the first paper of Quillen and Webster.
Full post as published by IPBiz on August 27, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.










